Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Environ Monit Assess ; 195(7): 833, 2023 Jun 10.
Article in English | MEDLINE | ID: mdl-37300645

ABSTRACT

The rainfall over the Indian region, governed majorly by the monsoonal flow, is a point of research in the perspective of climate change. In this paper, we compute the change points in the rainfall series at every grid of the India Meteorological Department (IMD) daily gridded rainfall data for a period of 120 years (1901 to 2020). The map shows clearly demarcated regions indicating different zones, where the rainfall statistics have altered at different periods. It is observed that in a major part of central India, the shift in rainfall intensity is mainly associated with the time frame 1955-1965; in the Indo-Gangetic plain, the changes are found to be more recent (1990), while the latest changes (post 2000) are observed particularly for North Eastern region and some parts along the East Indian coast. The changeover years are significant at a 95% confidence level for most part of the Indian landmass. The causes may be surmised due to moisture transport from the Arabian Sea (Central India), the presence of aerosol (Gangetic Plain), and the possible revival of monsoon due to land-ocean gradient (Eastern coast and North East India). This is the first-ever study which provides a comprehensive daily rainfall change point map over India using 120 years of gridded station data.


Subject(s)
Climate Change , Environmental Monitoring , Seasons , India , Aerosols/analysis
2.
Clin. transl. oncol. (Print) ; 23(3): 612-619, mar. 2021. tab, graf
Article in English | IBECS | ID: ibc-220896

ABSTRACT

Background Glioblastoma (GB) remains an incurable and deadly brain malignancy that often proves resistant to upfront treatment with temozolomide. Nevertheless, temozolomide remains the most commonly prescribed FDA-approved chemotherapy for GB. The DNA repair protein methylguanine-DNA methyl transferase (MGMT) confers resistance to temozolomide. Unsurprisingly temozolomide-resistant tumors tend to possess elevated MGMT protein levels or lack inhibitory MGMT promotor methylation. In this study, cultured human temozolomide resistance GB (43RG) cells were introduced to the MGMT inhibitor O6-benzylguanine combined with temozolomide and either LY2835219 (CDK 4/6 inhibitor) or LY2157299 (TGF-βRI inhibitor) seeking to overcome GB treatment resistance. Methods Treatment effects were assessed using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, western blot, cell viability, and cell cycle progression. Results Our in vitro study demonstrated that sequential treatment of O6-Benzylguanine with either LY2385219 or LY2157299-enhanced temozolomide enhanced sensitivity in MGMT+ 43RG cells. Importantly, normal human neurons and astrocytes remained impervious to the drug therapies under these conditions. Furthermore, LY2835219 has additional anti-proliferative effects on cell cycling, including induction of an RB-associated G (1) arrest via suppression of cyclin D-CDK4/6-Rb pathway. LY2157299 enhances anti-tumor effect by disrupting TGF-β–dependent HIF-1α signaling and by activating both Smad and PI3K-AKT pathways towards transcription of S/G2 checkpoints. Conclusion This study establishes the groundwork for the development of a combinatorial pharmacologic approach by using either LY2385219 or LY2157299 inhibitor plus O6-Benzylguanine to augment temozolomide response in temozolomide-resistant GB cells (AU)


Subject(s)
Humans , Temozolomide/pharmacology , Antineoplastic Agents, Alkylating/pharmacology , Tumor Suppressor Proteins/antagonists & inhibitors , Brain Neoplasms/drug therapy , DNA Modification Methylases/antagonists & inhibitors , Glioblastoma/drug therapy , Antineoplastic Combined Chemotherapy Protocols , Drug Resistance, Neoplasm , Signal Transduction
3.
Clin Transl Oncol ; 23(3): 612-619, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32710211

ABSTRACT

BACKGROUND: Glioblastoma (GB) remains an incurable and deadly brain malignancy that often proves resistant to upfront treatment with temozolomide. Nevertheless, temozolomide remains the most commonly prescribed FDA-approved chemotherapy for GB. The DNA repair protein methylguanine-DNA methyl transferase (MGMT) confers resistance to temozolomide. Unsurprisingly temozolomide-resistant tumors tend to possess elevated MGMT protein levels or lack inhibitory MGMT promotor methylation. In this study, cultured human temozolomide resistance GB (43RG) cells were introduced to the MGMT inhibitor O6-benzylguanine combined with temozolomide and either LY2835219 (CDK 4/6 inhibitor) or LY2157299 (TGF-ßRI inhibitor) seeking to overcome GB treatment resistance. METHODS: Treatment effects were assessed using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, western blot, cell viability, and cell cycle progression. RESULTS: Our in vitro study demonstrated that sequential treatment of O6-Benzylguanine with either LY2385219 or LY2157299-enhanced temozolomide enhanced sensitivity in MGMT+ 43RG cells. Importantly, normal human neurons and astrocytes remained impervious to the drug therapies under these conditions. Furthermore, LY2835219 has additional anti-proliferative effects on cell cycling, including induction of an RB-associated G (1) arrest via suppression of cyclin D-CDK4/6-Rb pathway. LY2157299 enhances anti-tumor effect by disrupting TGF-ß-dependent HIF-1α signaling and by activating both Smad and PI3K-AKT pathways towards transcription of S/G2 checkpoints. CONCLUSION: This study establishes the groundwork for the development of a combinatorial pharmacologic approach by using either LY2385219 or LY2157299 inhibitor plus O6-Benzylguanine to augment temozolomide response in temozolomide-resistant GB cells.


Subject(s)
Antineoplastic Agents, Alkylating/pharmacology , Brain Neoplasms/drug therapy , Cyclin-Dependent Kinase 4/antagonists & inhibitors , Cyclin-Dependent Kinase 6/antagonists & inhibitors , DNA Modification Methylases/antagonists & inhibitors , DNA Repair Enzymes/antagonists & inhibitors , Glioblastoma/drug therapy , Receptor, Transforming Growth Factor-beta Type I/antagonists & inhibitors , Temozolomide/pharmacology , Tumor Suppressor Proteins/antagonists & inhibitors , Aminopyridines/pharmacology , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Astrocytes/drug effects , Benzimidazoles/pharmacology , Brain Neoplasms/enzymology , Cell Cycle/drug effects , Cell Survival/drug effects , Cells, Cultured , Cyclin D/antagonists & inhibitors , Drug Resistance, Neoplasm/drug effects , G1 Phase Cell Cycle Checkpoints , Glioblastoma/enzymology , Guanine/analogs & derivatives , Guanine/pharmacology , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/drug effects , Neurons/drug effects , Phosphatidylinositol 3-Kinases/drug effects , Pyrazoles/pharmacology , Quinolines/pharmacology , Smad Proteins/drug effects
4.
Clin Transl Oncol ; 22(11): 2017-2025, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32253706

ABSTRACT

PURPOSE: Meningiomas are common brain tumors, the majority of which are considered benign. Despite surgery and/or radiation therapy, recurrence rates are approximately 8-10%. One likely cause is the dysregulation of cyclin D-cyclin-dependent kinases 4 and 6 (CDK4/6)-retinoblastoma (Rb) pathway, which controls the cell cycle restriction point. This pathway is commonly dysregulated in anaplastic meningioma cell lines (AM) and radiation-induced meningioma cells (RIM), making it a rational target for anti-meningioma therapy. In this study, we investigate the effect of a CDK4/6 inhibitor, palbociclib, with radiation in relevant pre-clinical models. METHODS: In vitro cell culture, ex vivo slice culture and in vivo cell line-derived orthotopic xenograft animal models of AM/RIM were utilized to assess treatment efficacy with palbociclib plus radiation. Treatment effects were examined by immunoblot, cell viability, apoptosis, and cell cycle progression. RESULTS: The in vitro and ex vivo studies demonstrate that palbociclib plus radiation treatment reduced proliferation and has additional effects on cell cycling, including induction of an RB-associated G (1) arrest in Rb+ AM and RIM cells, but not in Rb- cells. Our results also demonstrated reduced CDK4 and CDK6 expression as well as reduced E2F target gene expression (CCNA2 and CCNE2) with the combination therapy. MRI results in vivo demonstrated reduced tumor size at 5 weeks when treated with 14 days palbociclib (10 mg/kg) plus 6 Gy radiation compared to saline-treated tumors. Finally, no hepatic toxicity was found after treatments. CONCLUSION: A pre-clinical murine model provides preclinical evidence for use of palbociclib plus radiation as a therapeutic agent for Rb+ meningiomas.


Subject(s)
Antineoplastic Agents/therapeutic use , Meningeal Neoplasms/therapy , Meningioma/therapy , Neoplasms, Radiation-Induced/therapy , Piperazines/therapeutic use , Pyridines/therapeutic use , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Combined Modality Therapy , Cyclin-Dependent Kinase 4/antagonists & inhibitors , Cyclin-Dependent Kinase 6/antagonists & inhibitors , Humans , Male , Mice , Retinoblastoma Protein/metabolism
5.
Clin Transl Oncol ; 22(7): 1138-1145, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31732915

ABSTRACT

PURPOSE: N-myc downstream-regulated gene 2 (NDRG2) is down-regulated in grade-III meningioma [anaplastic meningioma (AM)] and associated with clinically aggressive behavior. Current therapies in the treatment of high-grade meningioma are lacking with limited success. This study aims to validate the effect of NDRG2-targeted therapy using structurally related bioactive triterpene compounds derived from the edible mushroom Ganoderma lucidum (ganoderic acid A:GA-A/ganoderic acid DM:GA-DM) in human AM in relevant pre-clinical models. METHODS: Tissue samples from the AM tumor regions of three human patients and control non-tumor samples were used to analyze the expression pattern of NDRG2. In vitro cell culture and in vivo cell-line-derived orthotopic xenograft animal models of AM were utilized to assess efficacy of treatment with GA-A/DM. RESULTS: Downregulation of NDRG2 expression was observed in surgically resected high-grade meningiomas compared to normal brain. These results prompt us to use NDRG2-targeting agents GA-A/DM. In vitro results showed that 72-h treatments of 25 µM GA-A/DM induced AM cell death, upregulate NDRG2 protein expression, downregulate NDRG2 promoter methylation in meningioma cells as compared to azacitidine and decitabine, the most commonly used demethylating agents. Our results also demonstrated that GA-A/DM does not have any detrimental effect on normal human neurons and arachnoid cells. GA-A/DM promoted apoptotic factors (Bax) while suppressing MMP-9, p-P13K, p-AKT, p-mTOR, and Wnt-2 protein expression. RNAi-mediated knockdown of NDRG2 protein expression increased tumor proliferation, while forced expression of wt-NDRG2 decreased proliferation in an in vitro model. Magnetic resonance (MR) imaging and Hematoxylin (H&E) staining demonstrated gross reduction of tumor volume in GA-A/DM treated mice at 5 weeks when compared with saline-treated orthotopic AM xenografted controls. There was an overall decrease in tumor cell proliferation with increased survival in GA-A/DM-treated animals. Enzyme assays showed that GA-A/DM did not negatively impact hepatic function. CONCLUSION: GA-A/DM may be a promising natural therapeutic reagent in the treatment of AM by suppressing growth via NDRG2 modulation and altering of intracellular signal pathways. We have shown it could potentially be an effective treatment for AM with decreased cellular proliferation in vitro, decreased tumor volume and increased survival in vivo.


Subject(s)
Heptanoic Acids/pharmacology , Lanosterol/analogs & derivatives , Meningeal Neoplasms/metabolism , Meningioma/metabolism , Triterpenes/pharmacology , Tumor Suppressor Proteins/drug effects , Aged , Anaplasia , Animals , Antimetabolites, Antineoplastic/pharmacology , Apoptosis/drug effects , Azacitidine/pharmacology , Cell Death/drug effects , DNA Methylation/drug effects , Decitabine/pharmacology , Down-Regulation , Gene Knockdown Techniques , Humans , In Vitro Techniques , Lanosterol/pharmacology , Matrix Metalloproteinase 9/drug effects , Matrix Metalloproteinase 9/metabolism , Meningeal Neoplasms/pathology , Meningioma/pathology , Mice , Mice, SCID , Middle Aged , Molecular Targeted Therapy , Neoplasm Grading , Phosphatidylinositol 3-Kinases/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Promoter Regions, Genetic , Proto-Oncogene Proteins c-akt/drug effects , Proto-Oncogene Proteins c-akt/metabolism , TOR Serine-Threonine Kinases/drug effects , TOR Serine-Threonine Kinases/metabolism , Tumor Suppressor Proteins/metabolism , Wnt2 Protein/drug effects , Wnt2 Protein/metabolism , Xenograft Model Antitumor Assays , bcl-2-Associated X Protein/drug effects , bcl-2-Associated X Protein/metabolism
6.
Environ Technol ; 39(5): 669-681, 2018 Mar.
Article in English | MEDLINE | ID: mdl-28327057

ABSTRACT

The major concerns of the modern society such as increasing population, climate change and economic development are imposing continuous stress on water and energy resources. The present work deals with the cultivation of green algae Desmodesmus abundans for optimum biomass productivity and lipid content as well as simultaneous removal of nitrate and phosphate from synthetic wastewater. The algal biomass is characterized by ultimate analysis, scanning electron microscopic analysis and thermogravimetric analysis. The effect of time, inoculum concentration and nitrate concentration on four responses (biomass productivity, lipid content, removal of nitrate and removal of phosphate) are studied by response surface methodology using central composite design. The quadratic models are found to be suitable for each response. At optimized experimental conditions, the algae showed biomass productivity of 46.96 mg L-1 day-1, lipid content of 16.23%, nitrate removal of 86.64% and phosphate removal of 87.52% after 27 days, when the initial inoculum concentration was 6% and nitrate concentration was 1.25 g L-1.


Subject(s)
Microalgae/physiology , Nitrates/analysis , Phosphates/analysis , Waste Disposal, Fluid/methods , Wastewater/chemistry , Water Pollutants, Chemical/analysis , Biodegradation, Environmental , Microalgae/growth & development
7.
Diabet Med ; 29(9): e255-62, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22248392

ABSTRACT

AIM: To test the hypothesis that fluconazole plus standard care is superior to the standard care for diabetic foot wounds infected with deep-seated fungal infections. METHODS: We carried out a randomized, controlled, open-label, parallel-arm study in 75 patients with both fungal and bacterial infections in deep tissues of diabetic foot wounds. Thirty-seven patients (control group) were given standard care (surgical debridement + culture-specific antibiotics + offloading + glycaemic control) and 38 patients (treatment group) were given fluconazole 150 mg daily plus standard care. Wound surface area was measured every 2 weeks until the endpoints (complete epithelialization or skin grafting) were met. RESULTS: By week 4, the mean wound surface area reduced to 27.3 from 111.5 cm(2) in the treatment group, as opposed to 67.1 from 87.3 cm(2) in the control group. Subsequently, the mean wound surface areas were remarkably smaller in the treatment group compared with the control group, and statistically significant differences (P ≤ 0.05) in mean wound surface area were observed between the treatment group and the control group at week 6. However, no statistically significant (P ≤ 0.47) difference in complete healing was observed between the treatment group and the control group, 20 vs. 24. The mean wound healing time for the treatment group was 7.3 weeks, whereas for the control group it was 11.3 weeks (P ≤ 0.022). Similarly, the probability of wound healing in the treatment group was 50 vs. 20% in the control group at week 10. CONCLUSIONS: Fluconazole plus standard care was superior to standard care alone in accelerating wound reduction among patients with diabetes with deep-seated fungal infections in diabetic foot wounds. Those in the treatment group who did heal, healed more quickly (P ≤ 0.022), but overall healing was not different.


Subject(s)
Antifungal Agents/pharmacology , Diabetes Mellitus, Type 2/complications , Diabetic Foot/microbiology , Diabetic Foot/therapy , Mycoses/drug therapy , Wound Healing/drug effects , Aged , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Bacterial Infections/drug therapy , Bacterial Infections/epidemiology , Blood Glucose/metabolism , Case-Control Studies , Comorbidity , Debridement , Diabetic Foot/epidemiology , Female , Fluconazole/pharmacology , Fluconazole/therapeutic use , Follow-Up Studies , Humans , Male , Middle Aged , Mycoses/epidemiology , Treatment Outcome , Wound Healing/physiology
8.
Curr Cancer Drug Targets ; 10(7): 660-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20578991

ABSTRACT

The present study deals with the evaluation of the efficacy of oxaliplatin and paclitaxel combination as a potential strategy in controlling HNSCC cell proliferation and the assessment of correlation between occurrence of apoptosis and changes in expression of survivin (IAP). The panel cell lines included two HNSCC cell lines (Cal27 and NT8e) and one normal cell line (293) with differential level of survivin expression in accordance with chemosensitivity. The cytotoxicity and effect of drugs on apoptosis was determined, separately and in combination. Combined treatment of cells with paclitaxel and oxaliplatin resulted in significantly higher cytotoxicity as compared to individual single drug treatment. Cytotoxicity was prominent in paclitaxel to oxaliplatin (pacl-oxal) sequence treatment with an approximate two-fold increase in apoptosis as compared to oxaliplatin to paclitaxel (oxal-pacl) sequence treatment. Paclitaxel treatment also caused increased survivin expression showing reduced apoptosis at low concentration. Oxaliplatin, when combined with paclitaxel, decreased the survivin level with increased cell death. Inhibition of survivin by a small interfering RNA (siRNA) method also increased the sensitivity of the cancer cell lines to paclitaxel whereas over-expression of survivin in the transfected 293-cell line provided resistance. In conclusion, the interaction between drugs was synergistic and schedule-dependent. Survivin played a critical role in paclitaxel resistance through the suppression of apoptosis, and a significant induction of apoptosis was observed when oxaliplatin was combined with paclitaxel at least in part by the down-regulation of survivin.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Squamous Cell/drug therapy , Head and Neck Neoplasms/drug therapy , Inhibitor of Apoptosis Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Organoplatinum Compounds/pharmacology , Paclitaxel/pharmacology , Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Administration Schedule , Drug Resistance, Neoplasm , Drug Synergism , Gene Expression Regulation, Neoplastic/drug effects , Gene Silencing , Humans , Inhibitor of Apoptosis Proteins/genetics , Microtubule-Associated Proteins/genetics , Organoplatinum Compounds/administration & dosage , Oxaliplatin , Paclitaxel/administration & dosage , RNA, Messenger/metabolism , RNA, Small Interfering , Survivin
9.
New Delhi; MaCmillan India; 2003. xi,281 p. ilus, tab.
Monography in English | Sec. Munic. Saúde SP, HSPM-Acervo | ID: sms-6374
10.
New Delhi; MaCmillan India; 2002. x,166 p. ilus, tab, graf.
Monography in English | Sec. Munic. Saúde SP, HSPM-Acervo | ID: sms-6375
11.
Clin Orthop Relat Res ; (319): 130-40, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7554622

ABSTRACT

The proximally porous-coated, modular S-ROM femoral component was used in 52 complex total hip revisions done in 48 patients. These patients had severe bone loss, leg length inequality, and instability. Twenty-two patients required structural femoral allografts; 8 had previous resection arthroplasties for sepsis. The mean number of previous hip operations was 3. The stem was press fit, and the metaphyseal sleeve was selectively cemented to the allograft. The preoperative Harris rating was 44 points; at a mean of 3 years, followup was 82 points. Eighty-four percent of the patients were satisfied with their outcomes. No radiographic or histologic evidence of fretting at the modular sleeve-stem junction or along the stem was seen. Significant thigh pain persisted in 2 patients and was directly related to stem diameters > 17 mm. Complications in these complex cases were not infrequent, reflecting the need for allograft augmentation, and included greater trochanter bursitis and nonunion in 20 hips, minor nonpropagating fracture in 13 hips, and 12 dislocations. Mechanical loosening occurred in 5 hips. There were no complications attributable to the S-ROM modular femoral component, and the prosthesis has proven to be versatile and did well in these very difficult cases.


Subject(s)
Femur/surgery , Hip Prosthesis/methods , Adult , Bone Transplantation/methods , Female , Femur/diagnostic imaging , Hip Fractures/etiology , Hip Joint/diagnostic imaging , Humans , Intraoperative Complications/etiology , Male , Middle Aged , Patient Satisfaction , Postoperative Complications/etiology , Prosthesis Design , Radiography , Range of Motion, Articular , Reoperation/methods , Transplantation, Homologous
12.
J Bone Joint Surg Br ; 76(6): 930-7, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7983122

ABSTRACT

Patellofemoral problems are a common cause of morbidity and reoperation after total knee arthroplasty. We made a prospective study of 52 patients who had bilateral arthroplasty (104 knees) and in whom the patella was resurfaced on one side and not on the other. A movable-bearing prosthesis with an anatomical femoral groove was implanted on both sides by the same surgeon using an otherwise identical technique. The mean follow-up was 5.24 years (2 to 10). In the 30 available patients (60 knees) there was no difference between the two sides in subjective preference, performance on ascending and descending stairs or the incidence of anterior knee pain. Radiographs showed no differences in prosthetic alignment, femoral condylar height, patellar congruency or joint line position. The use of an appropriate prosthetic design and careful surgical technique can provide equivalent results after knee arthroplasty with or without patellar resurfacing. Given the indications and criteria, which we discuss, retention of the patellar surface is an acceptable option.


Subject(s)
Knee Joint/surgery , Knee Prosthesis/methods , Patella/surgery , Postoperative Complications/surgery , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Knee Joint/diagnostic imaging , Knee Joint/pathology , Knee Joint/physiopathology , Male , Middle Aged , Postoperative Care , Prospective Studies , Prosthesis Design , Radiography , Range of Motion, Articular , Reoperation , Surface Properties , Traction
13.
World J Microbiol Biotechnol ; 9(3): 291-4, 1993 May.
Article in English | MEDLINE | ID: mdl-24420028

ABSTRACT

A new species of the endogonaceous fungus Gigaspora, isolated from the Indian semi-arid region, is described. The fungus, named G. tuberculata, produces rusty-brown azygospores with septate subtending hypha. The azygospores bear warts all over the outer wall. The shape, size and general appearance of these spores resemble those of Scutellospora persica.

14.
Plant Physiol ; 95(2): 492-7, 1991 Feb.
Article in English | MEDLINE | ID: mdl-16668011

ABSTRACT

Phycobilisomes from the nonchromatic adapting cyanobacterium Spirulina platensis are composed of a central core containing allophycocyanin and rods with phycocyanin and linker polypeptides in a regular array. Room temperature absorption spectra of phycobilisomes from this organism indicated the presence of phycocyanin and allophycocyanin. However, low temperature absorption spectra showed the association of a phycobiliviolin type of chromophore within phycobilisomes. This chromophore had an absorption maximum at 590 nanometers when phycobilisomes were suspended in 0.75 molar K-phosphate buffer (pH 7.0). Purified phycocyanin from this cyanobacterium was found to consist of three subparticles and the phycobiliviolin type of chromophore was associated with the lowest density subparticle. Circular dichroism spectra of phycocyanin subparticles also indicated the association of this chromophore with the lowest density subparticle. Absorption spectral analysis of alpha and beta subunits of phycocyanin showed that phycobiliviolin type of chromophore was attached to the alpha subunit, but not the beta subunit. Effect of light quality showed that green light enhanced the synthesis of this chromophore as analyzed from the room temperature absorption spectra of phycocyanin subparticles and subunits, while red or white light did not have any effect. Low temperature absorption spectra of phycobilisomes isolated from green, red, and white light conditions also indicated the enhancement of phycobiliviolin type of chromophore under green light.

15.
Anal Biochem ; 172(2): 377-81, 1988 Aug 01.
Article in English | MEDLINE | ID: mdl-3142292

ABSTRACT

This paper describes a method for the rapid isolation of phycobilisomes using a cationic detergent, CTAB (cetyltrimethylammonium bromide). The method has distinct advantages over those currently in use in that (i) release of intact phycobilisomes from cells in the presence of CTAB occurs in 40 s (as compared to 40-60 min of incubation required with Triton X-100), thereby reducing the chances of proteolysis of the component phycobiliproteins; and (ii) these phycobilisome preparations have reduced chlorophyll contamination in the initial stages. In addition this method also helps retain the structural and functional properties, as evidenced by spectroscopy and sodium dodecyl sulfate-polyacrylamide gel analysis.


Subject(s)
Cyanobacteria/analysis , Plant Proteins/isolation & purification , Cell Membrane/analysis , Cetrimonium , Cetrimonium Compounds , Detergents , Electrophoresis, Polyacrylamide Gel , Hydrolysis , Light-Harvesting Protein Complexes , Octoxynol , Phycobilisomes , Polyethylene Glycols , Spectrometry, Fluorescence
16.
Int J Oral Maxillofac Surg ; 15(2): 187-9, 1986 Apr.
Article in English | MEDLINE | ID: mdl-3083022

ABSTRACT

Temporal augmentation was achieved by introducing a 15 cm long fascialata strip into the tail of the temporal tendon intraorally, intertwining it throughout the length of the temporalis muscle and its fascia bilaterally. The strips were pulled taut after closing the mouth, and fixed firmly near the posteriosuperior origin of the muscle.


Subject(s)
Fascia Lata/transplantation , Fascia/transplantation , Joint Dislocations/surgery , Masticatory Muscles/surgery , Temporal Muscle/surgery , Temporomandibular Joint Disorders/surgery , Tendons/surgery , Humans , Immobilization , Recurrence
17.
Can J Microbiol ; 29(10): 1470-4, 1983 Oct.
Article in English | MEDLINE | ID: mdl-6318943

ABSTRACT

An apparently new species of Clostridium was isolated from mud samples obtained from a stagnant lake near Athens, Georgia. These organisms were able to utilize inorganic pyrophosphate as a source of energy for growth, a phenomenon representing the simplest ATP-generating system in the biological world.


Subject(s)
Clostridium/isolation & purification , Diphosphates/metabolism , Water Microbiology , Anaerobiosis , Clostridium/classification , Clostridium/metabolism , Clostridium/ultrastructure , Culture Media
18.
Int J Oral Surg ; 10(Suppl 1): 21-6, 1981.
Article in English | MEDLINE | ID: mdl-6807881

ABSTRACT

This paper deals with a one-stage cosmetically modified operative procedure for resection and simultaneous reconstruction of oral malignancies restricted to the lower 1/3 of the face, in a group of patients falling into stratification staging 2-6, with a moderately well-differentiated squamous cell histological picture. Primary osseous defects have been restored in autogenous full thickness iliac crest bone graft which is split and slid, not only to gain adequate length but also to prepare matching steps for complete osseous compression. It is easy to contour and gives an excellent cosmetic result. Bioacceptable stainless steel implants have also been tried in earlier cases. This one-stage approach supersedes the previously complicated procedures of delayed multi-stage reconstruction and had an 80% success rate in the selected groups with a 4-year follow-up.


Subject(s)
Carcinoma, Squamous Cell/rehabilitation , Mandibular Neoplasms/rehabilitation , Mandibular Prosthesis , Surgery, Plastic/methods , Adult , Bone Plates , Bone Transplantation , Carcinoma, Squamous Cell/surgery , Female , Humans , Male , Mandibular Neoplasms/surgery , Middle Aged , Stainless Steel
19.
Experientia ; 35(7): 854-5, 1979 Jul 15.
Article in English | MEDLINE | ID: mdl-113245

ABSTRACT

ATP-sulphurylase from an unicellular blue-green alga, Spirulina platensis was localized in the soluble fractions of cell-free homogenate, and it was stable for over 3 weeks at -6 degrees C.


Subject(s)
Cyanobacteria/enzymology , Nucleotidyltransferases/metabolism , Sulfate Adenylyltransferase/metabolism , Kinetics , Subcellular Fractions/enzymology
20.
Folia Microbiol (Praha) ; 24(6): 501-2, 1979.
Article in English | MEDLINE | ID: mdl-574481

ABSTRACT

Dual infections of Glycine max with VA endophytes and Rhizobium, compared with Rhizobium alone, increased the number and weight of nodules significantly in natural field soil and obviated the need of phosphate application for successful nodulation.


Subject(s)
Agriculture , Fungi/growth & development , Glycine max , Rhizobium/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...